Jane Street’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-63,922
| Closed | -$4.35M | – | 6867 |
|
2022
Q3 | $4.35M | Sell |
63,922
-165,937
| -72% | -$11.3M | ﹤0.01% | 1276 |
|
2022
Q2 | $7.34M | Buy |
229,859
+18,467
| +9% | +$590K | ﹤0.01% | 828 |
|
2022
Q1 | $7.32M | Buy |
211,392
+97,073
| +85% | +$3.36M | ﹤0.01% | 899 |
|
2021
Q4 | $3.35M | Buy |
114,319
+53,592
| +88% | +$1.57M | ﹤0.01% | 1393 |
|
2021
Q3 | $1.55M | Buy |
60,727
+16,713
| +38% | +$426K | ﹤0.01% | 2142 |
|
2021
Q2 | $1.54M | Buy |
44,014
+11,161
| +34% | +$391K | ﹤0.01% | 2062 |
|
2021
Q1 | $1.34M | Sell |
32,853
-63,578
| -66% | -$2.59M | ﹤0.01% | 2134 |
|
2020
Q4 | $4.18M | Buy |
96,431
+64,235
| +200% | +$2.78M | ﹤0.01% | 849 |
|
2020
Q3 | $1.78M | Sell |
32,196
-71,646
| -69% | -$3.95M | ﹤0.01% | 1299 |
|
2020
Q2 | $6.56M | Buy |
+103,842
| New | +$6.56M | ﹤0.01% | 549 |
|
2020
Q1 | – | Sell |
-7,005
| Closed | -$557K | – | 4128 |
|
2019
Q4 | $557K | Sell |
7,005
-7,157
| -51% | -$569K | ﹤0.01% | 2151 |
|
2019
Q3 | $687K | Sell |
14,162
-12,480
| -47% | -$605K | ﹤0.01% | 1872 |
|
2019
Q2 | $1.4M | Buy |
26,642
+14,673
| +123% | +$772K | ﹤0.01% | 1317 |
|
2019
Q1 | $634K | Buy |
11,969
+4,711
| +65% | +$250K | ﹤0.01% | 2083 |
|
2018
Q4 | $298K | Buy |
7,258
+302
| +4% | +$12.4K | ﹤0.01% | 2539 |
|
2018
Q3 | $264K | Sell |
6,956
-19,820
| -74% | -$752K | ﹤0.01% | 2911 |
|
2018
Q2 | $1.21M | Buy |
26,776
+9,154
| +52% | +$414K | ﹤0.01% | 1485 |
|
2018
Q1 | $851K | Buy |
17,622
+7,132
| +68% | +$344K | ﹤0.01% | 1722 |
|
2017
Q4 | $413K | Buy |
10,490
+4,043
| +63% | +$159K | ﹤0.01% | 2185 |
|
2017
Q3 | $200K | Buy |
+6,447
| New | +$200K | ﹤0.01% | 2638 |
|
2017
Q2 | – | Sell |
-8,780
| Closed | -$324K | – | 3369 |
|
2017
Q1 | $324K | Buy |
+8,780
| New | +$324K | ﹤0.01% | 2162 |
|
2016
Q1 | – | Sell |
-25,679
| Closed | -$830K | – | 3165 |
|
2015
Q4 | $830K | Buy |
+25,679
| New | +$830K | 0.01% | 1199 |
|